StopDownOpen the app

Funding · Healthcare & Life Sciences

Wholeleaf in advanced talks to raise Rs 7.5 crore

By ·

Date
Company
Wholeleaf
What it does
Natural pain therapeutics company
Kind
Funding
Amount
Rs 5 crore
Stage
seed
Founded
2021
Sector
Healthcare & Life Sciences

What they do

Wholeleaf makes medically oriented natural pain therapeutics for chronic and neuropathic pain

What happened

It is in advanced talks to raise Rs 7.5 crore from IPV and Benzai 10 Capital

Why it matters

The company has an annual recurring revenue of Rs 18 crore and nearly 2,000 retail outlets

The details

  • Wholeleaf is in advanced talks to raise Rs 7.5 crore from IPV and Benzai 10 Capital.
  • The company makes medically oriented natural pain therapeutics.
  • It focuses on chronic and neuropathic pain management.
  • Wholeleaf leads the cannabinoid pain therapeutics category in India.
  • Its portfolio includes oral tinctures and topical formulations for migraines, arthritis, fibromyalgia, menstrual pain, anxiety, and sleeplessness.
  • The company has a pipeline for chronic neuropathic pain solutions.
  • It has raised Rs 5 crore to date, including a seed round of Rs 1.5 crore from Shark Tank India investors and Rs 3.5 crore from ah! Ventures and angels.

The bigger picture

  • It will also scale distribution and enhance brand visibility both online and offline.
  • The company plans to expand from nearly 2,000 retail outlets to 5,000–7,000 this year.
  • Target cities for deeper penetration include Bengaluru, Mumbai, Hyderabad, Kolkata, Ahmedabad, Goa, and Chennai.

About the business

  • Wholeleaf is a medically oriented natural pain therapeutics company launched in 2021.
  • It focuses on chronic and neuropathic pain management.
  • The company leads the cannabinoid pain therapeutics category in India.
  • Its product portfolio includes oral tinctures and topical formulations for migraines, arthritis, fibromyalgia, menstrual pain, anxiety, and sleeplessness.
  • Wholeleaf has a pipeline for chronic neuropathic pain solutions.
  • Product development is physician-led with multi-stage validation including safety testing, pilot studies, and third-party government-certified lab assessments.
  • The company has nearly 2,000 retail outlets, primarily in Delhi-NCR.
  • It has an annual recurring revenue of Rs 18 crore.

What happens next

  • Wholeleaf plans to use the funds to accelerate offline retail expansion, strengthen product development, scale distribution, and enhance brand visibility online and offline.
  • It aims to expand from nearly 2,000 retail outlets to 5,000–7,000 this year.
  • Target cities for deeper penetration include Bengaluru, Mumbai, Hyderabad, Kolkata, Ahmedabad, Goa, and Chennai.

The deal

Type
funding

Investors

  • IPV (participated) — IPV is an institutional investor participating in this round.
  • Benzai 10 Capital (participated) — Benzai 10 Capital is an institutional investor participating in this round.

Founders

  • Shivraj Sharma, Founder and CEO

Read it as a card in the app

More on Wholeleaf

Everything on Wholeleaf →

Same day

All startup news on 8 June 2026 →